Diagnosticos da America (BSP:DASA3) Other Financing: R$-282 Mil (TTM As of Mar. 2026)


BSP:DASA3 Diagnosticos da America SA BSP:DASA3
53 GF Score
Price R$2.62
GF Value R$1.70
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Diagnosticos da America Other Financing?

Diagnosticos da America BSP:DASA3 -6.09% 53 Other Financing is R$-282 Mil as of Mar. 2026. GuruFocus rates BSP:DASA3 with a GF Score™ of 53/100 and a GF Value™ of R$1.70 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Diagnosticos da America's Other Financing for the three months ended in Mar. 2026 was R$-1 Mil.

Diagnosticos da America's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was R$-282 Mil.

Diagnosticos da America Other Financing Historical Data

* Premium members only.

The historical data trend for Diagnosticos da America's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnosticos da America Other Financing Chart

Diagnosticos da America Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -571.71 -1,411.52 -267.51 -353.73 -334.73

Diagnosticos da America Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.81 -22.78 -2.36 -255.79 -0.68
BSP:DASA3
53GF Score
Diagnosticos da America SA BSP:DASA3
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnosticos da America Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-282 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of R$-282 Mil mean?
Diagnosticos da America (BSP:DASA3) has a Other Financing of R$-282 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Diagnosticos da America and its competitors.
Is Diagnosticos da America's Other Financing too high?
Diagnosticos da America's current Other Financing is R$-282 Mil. Overall, Diagnosticos da America has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diagnosticos da America's Other Financing compare to TMO and DHR?
Diagnosticos da America's Other Financing of R$-282 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Diagnostics & Research company?
A good Other Financing depends on the Medical Diagnostics & Research industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Diagnosticos da America and its competitors. Diagnosticos da America's current Other Financing is R$-282 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnosticos da America stock overvalued right now?
Based on GuruFocus' analysis, Diagnosticos da America (BSP:DASA3) is currently considered Significantly Overvalued. The stock's GF Value™ is R$1.70, compared to a current price of R$2.62 — trading 54.1% above its estimated fair value. The current Other Financing is R$-282 Mil. Diagnosticos da America's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Diagnosticos da America (BSP:DASA3), the current Other Financing is R$-282 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diagnosticos da America (BSP:DASA3) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnosticos da America stock appears to be overvalued. The current stock price of R$2.62 is trading 54.1% above its estimated GF Value™ of R$1.70. GuruFocus considers Diagnosticos da America to be Significantly Overvalued.

Key valuation signals for BSP:DASA3:

  • Other Financing: R$-282 Mil
  • GF Value™: R$1.70 vs. price of R$2.62 (54.1% above fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the BSP:DASA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diagnosticos da America Business Description

Address Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
53GF Score

Get the complete analysis for BSP:DASA3

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$2.62
Price
R$1.70
GF Value